From Risk Categories to Risk-Adapted Care: Comparing the 2025 American Thyroid Association and 2024 Korean Thyroid Association Risk Stratification Systems in Differentiated Thyroid Cancer
Endocrinology and Metabolism · 30.06.2026 · 41 (3) · 383-386
DOI: 10.3803/enm.2026.3118 ↗Kurz gefasst
Editorial in der Zeitschrift Endocrinology and Metabolism, erschienen am 30.06.2026. Verfasst von Won Gu Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea…. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
In differentiated thyroid cancer (DTC) management, initial risk stratification is a fundamental component that provides the basis for decisions regarding adjuvant therapy and follow-up intensity. The 2025 American Thyroid Association (ATA) and 2024 Korean Thyroid Association (KTA) guidelines employ recurrence risk-based stratification systems at the time of diagnosis. Although the overall framework is comparable, there exists a key structural difference: the ATA guideline adopts a four-tier system (low, low-intermediate, intermediate-high, and high risks) [1], whereas the KTA guideline maintains a three-tier sys-tem (low, intermediate, and high risks) [2,3]. This modification by the ATA may be interpreted as an effort to further refine the heterogeneous intermediate-risk group, which had been associated with a broad range of recurrence risk in previous guidelines [1,4]. These differences should not be interpreted merely as differences in classification structure, because initial risk categories may influence subsequent decisions regarding adjuvant radioactive iodine therapy, thyroid-stimulating hormone suppression, and postoperative surveillance intensity. Because many clinicians may not have the opportunity to compare both guidelines in detail, Table 1 provides a side-by-side summary of the major category-defining differences be-tween the 2024 KTA and 2025 ATA
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. wongukim@amc.seoul.kr.
- Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
Zitieren
APA
Kim, W. G., & Kim, M. (2026). From Risk Categories to Risk-Adapted Care: Comparing the 2025 American Thyroid Association and 2024 Korean Thyroid Association Risk Stratification Systems in Differentiated Thyroid Cancer. Endocrinology and Metabolism, 41(3), 383-386. https://doi.org/10.3803/enm.2026.3118
Vancouver
Kim WG, Kim M. From Risk Categories to Risk-Adapted Care: Comparing the 2025 American Thyroid Association and 2024 Korean Thyroid Association Risk Stratification Systems in Differentiated Thyroid Cancer. Endocrinology and Metabolism. 2026;41(3):383-386. doi:10.3803/enm.2026.3118
BibTeX
@article{Kim2026,
author = {Kim, Won Gu and Kim, Mijin},
title = {From Risk Categories to Risk-Adapted Care: Comparing the 2025 American Thyroid Association and 2024 Korean Thyroid Association Risk Stratification Systems in Differentiated Thyroid Cancer},
journal = {Endocrinology and Metabolism},
year = {2026},
volume = {41},
number = {3},
pages = {383--386},
doi = {10.3803/enm.2026.3118}
}
EUVIMED